OpenAlex
PricingAboutJobs
Log inGet started
Work

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients

HTML

Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: AIDS
DOI: 10.1097/01.aids.0000131332.30548.92
Authors: Joseph C Gathe, Prudence Ive, Robin Wood, Dirk Schürmann, Nicholaos C Bellos, Edwin DeJesus, Andrzej Gladysz, Cindy Garris, Jane Yeo
Institutions: University of Cape Town, Charité – Universitätsmedizin Berlin, University of Wrocław, Wroclaw Medical University, GlaxoSmithKline (United Kingdom)
Language: English

Topic: HIV/AIDS drug development and treatment
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: fosamprenavir, ritonavir, nelfinavir, HIV-1 protease inhibitors, once-daily dosing, antiretroviral-naive patients, viral suppression, CD4 count, diarrhea, fasting lipid profile, drug sensitivity, abacavir, lamivudine
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1971758213
FWCI: 19.51
Cites: 18
Cited by: 209
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security